[VETOQUINOL] H1 2019 RESULTS

EBITDA taking into account IFRS 16 2019 H1 Results 28 €m 6/30/2019 6/30/2018* Net income excl. earnings of associates 12.8 15.9 Income tax expense 4.9 4.7 Net financial items 0.3 (0.2) Provisions recorded under non-recurring operating income and expenses (0.2) (0.5) Provisions and write-backs (0.3) 1.1 Depreciation and amortization 6.7 6.4 Depreciation and amortization - IFRS 2.1 2.4 EBITDA 26.2 29.9 * Restated for the impact of the application of the IFRS 16 standard